The Asian Scientist 100
Lu Ke
Institution
Chinese Academy of Sciences
Country
China
Field
Materials Sciences
Lu is the winner of the 2020 Future Science Prize (Physical Science Prize) for discovering and synthesizing a superior nanotwinned structure and gradient nanostructure.
(Photo: Future Science Prize)
AWARDS
- Future Science Prize 2020
Related articles
Chinese Researchers Simulate Complete H1N1 Virus With NVIDIA Supercomputer
Chinese researchers have achieved a major breakthrough in the race to battle influenza by creating the world's first computer simulation of a whole H1N1 influenza virus at the atomic level.
Chinese Researchers Pinpoint Origins Of H7N9 Avian Flu
Chinese researchers have identified the origins of the novel H7N9 influenza virus that has led to 109 human infections and 22 deaths in China.
H1N1 Influenza Vaccine From A*STAR & Cytos Enters Phase I Trials
Singapore's A*STAR and Switzerland's Cytos Biotechnology AG today announced the initiation of Phase I trials for their H1N1 influenza vaccine candidate.
New Details About H7N9 Infection Uncovered
Researchers have uncovered new information about the latest strain of type A influenza, known as H7N9.
Studying Animals To Improve Human Health
Research into animals, both common and obscure, are yielding insights into human health that are not always expected, writes Shuzhen Sim.
Chinese CDC Study Finds High Risk Features Of H7N9 Virus
A new study from the Chinese CDC suggests that the H7N9 influenza A virus possesses a suite of biological features that may be a serious threat to humans.
Taiwan Vaccine Maker Completes PhIII Trials On H7N9 Influenza Vaccine
Taiwan-based vaccine maker Adimmune Corp says that it has the capacity to produce up to three million units per month of its preliminary H7N9 influenza vaccine.
Adimmune To Begin Phase III Flu Vaccine Trials In China
Taiwanese vaccine maker Adimmune Corp has received approval from the Chinese government to start Phase III clinical trials of its flu vaccine in China.
Study: China Should Consider National Flu Vaccination Plan
Scientists suggest that China should tailor its influenza vaccination strategies to account for its three distinct flu regions.